Evidence map›Paper›PMID 36336552›Full record

ReviewTrends in biochemical sciences2023

The NLRP3 inflammasome: activation and regulation.

Jie Xu, Gabriel Núñez

Open access · greenAbstract readReview
In one paragraph

Review in Trends in biochemical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 331 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
331citing papers in PubMed, 3 pooled it
38.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

331 citing papers in PubMed, 3 syntheses or guidelines pooled it, 492 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Protein kinase F regulates the virulence ofInfection and immunity · 2026
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. The Polyphenol-EnrichedFoods (Basel, Switzerland) · 2026
    Article
  16. Article
  17. VlPAG/DRN Microglia Drive Neuropathic Pain-Induced Depression via a Defined Neuroimmune Axis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  18. Review
  19. Review
  20. Review

271 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jie XuDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.
Gabriel NúñezDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: gabriel.nunez@umich.edu.
University of Michigan–Ann Arbor · US

Funding

Cryopyrin/NLRP3 Signaling in Inflammation and Innate ImmunityR37AI063331 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NUNEZ, GABRIEL · 2016 to 2025
$3.9M
NIAID NIH HHS R37 AI063331
6 · The paper itself

Abstract

The NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome is a cytoplasmic supramolecular complex that is activated in response to cellular perturbations triggered by infection and sterile injury. Assembly of the NLRP3 inflammasome leads to activation of caspase-1, which induces the maturation and release of interleukin-1β (IL-1β) and IL-18, as well as cleavage of gasdermin D (GSDMD), which promotes a lytic form of cell death. Production of IL-1β via NLRP3 can contribute to the pathogenesis of inflammatory disease, whereas aberrant IL-1β secretion through inherited NLRP3 mutations causes autoinflammatory disorders. In this review, we discuss recent developments in the structure of the NLRP3 inflammasome, and the cellular processes and signaling events controlling its assembly and activation.

Indexed as

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinCaspase 1Gene ExpressionInterleukin-1betaSignal TransductionCaspase 1InflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinGolgimetabolismmitochondriaphosphorylationpotassium effluxubiquitination

Identifiers

PMID36336552
PMCPMC10023278
OpenAlexW4308202696

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.